Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Aprea Therapeutics announced that its President and CEO, Dr. Oren Gilad, will present at the H.C. Wainwright 28th Annual Global Investment Conference. The company focuses on developing precision medicine oncology therapies targeting biomarker-defined cancers using small molecule inhibitors, with clinical programs in solid tumors including ovarian, …